| Casale, Thomas |
| Recruiting | 3 | 450 | Europe, US, RoW | LY3650150, Placebo, Standard therapy for INCS | Eli Lilly and Company | Perennial Allergic Rhinitis (PAR) | 10/25 | 02/27 | | |
NCT04430179: Dupilumab Severe Eosinophilic Chronic Sinusitis Without Nasal Polyposis |
|
|
| Recruiting | 2 | 30 | US | Dupilumab 300 MG/2 ML Subcutaneous Solution [DUPIXENT], Placebo | University of South Florida | Severe Eosinophilic Chronic Sinusitis Without Nasal Polyposis | 07/23 | 12/23 | | |
NCT05363670: Administration of ARS-1 or Albuterol in Subjects With Persistent Asthma |
|
|
| Completed | 2 | 18 | US | ARS-1, Albuterol MDI, Placebo | ARS Pharmaceuticals, Inc. | Asthma | 02/24 | 02/24 | | |
CALM-CSU, NCT06077773: Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effects of EP262 in Subjects With Chronic Spontaneous Urticaria |
|
|
| Recruiting | 2 | 154 | Europe, Canada, US | Oral EP262, Placebo | Escient Pharmaceuticals, Inc | Chronic Spontaneous Urticaria | 06/25 | 07/25 | | |
NCT05440643: Peanut Sublingual Immunotherapy (SLIT)-Tablet for Treatment of Peanut Allergy |
|
|
| Recruiting | 1/2 | 192 | Canada, US | Peanut SLIT-tablet, Placebo | ALK-Abelló A/S, Parexel | Peanut Allergy | 01/26 | 02/26 | | |
| Smith, Catherine |
NCT02630121: Effect of Oxymetazoline Hydrochloride in Combination With Fluticasone Propionate on the Apnea Hypopnea Index (AHI) in Subject With Persistent Nasal Congestion and Mild Obstructive Sleep Apnea |
|
|
| Recruiting | 4 | 52 | US | Oxymetazoline Hydrochloride, Afrin, Placebo, Nasal saline | University of South Florida | Sleep Apnea, Chronic Nasal Congestion | 04/24 | 04/24 | | |
NCT04430179: Dupilumab Severe Eosinophilic Chronic Sinusitis Without Nasal Polyposis |
|
|
| Recruiting | 2 | 30 | US | Dupilumab 300 MG/2 ML Subcutaneous Solution [DUPIXENT], Placebo | University of South Florida | Severe Eosinophilic Chronic Sinusitis Without Nasal Polyposis | 07/23 | 12/23 | | |
NCT04129931: PrecISE (Precision Interventions for Severe and/or Exacerbation-Prone Asthma) Network Study |
|
|
| Active, not recruiting | 2 | 395 | US | MCT, Breathe Better Diet (BBD), Clazakizumab, Anti-interleukin 6 monoclonal antibody, Anti-IL-6 mAb, BMS-945429, ALD518, Broncho-Vaxom, OM-85 BV VEGETAL, Imatinib Mesylate, Gleevec, Zoleta, Glivec, Ziatir, Cavosonstat, N91115, Placebo | University of North Carolina, Chapel Hill, National Heart, Lung, and Blood Institute (NHLBI) | Asthma | 12/24 | 12/24 | | |
NCT05440643: Peanut Sublingual Immunotherapy (SLIT)-Tablet for Treatment of Peanut Allergy |
|
|
| Recruiting | 1/2 | 192 | Canada, US | Peanut SLIT-tablet, Placebo | ALK-Abelló A/S, Parexel | Peanut Allergy | 01/26 | 02/26 | | |
| Terminated | 1/2 | 40 | US | ZN-d5 ZN-c3, Study Drug, ZN-c3 | K-Group Alpha, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc. | Acute Myeloid Leukemia (AML) | 07/24 | 07/24 | | |
|
NCT04590092: Pessary Use for Stress Urinary Incontinence in Pregnancy |
|
|
| Recruiting | N/A | 60 | Canada | Cooper Surgical Ring Pessary with Incontinence Knob | University of British Columbia | Stress Urinary Incontinence, Pregnancy Related | 09/22 | 09/22 | | |
| Recruiting | N/A | 119 | Europe | | King's College London, Guy's and St Thomas' NHS Foundation Trust, Royal Free Hospital NHS Foundation Trust | Idiopathic Recurrent Pericarditis | 06/24 | 06/24 | | |
NCT06722378: A Trial to Improve Family Clinical Note Access and Outcomes for Hospitalized Children |
|
|
| Not yet recruiting | N/A | 630 | US | Access to medical notes | University of Wisconsin, Madison, Agency for Healthcare Research and Quality (AHRQ), Pediatric Research in Inpatient Settings (PRIS) Network | Hospitalized Child, Pediatric Patient Safety, Medical Errors, Parental Engagement in Care, Inpatient Pediatric Care | 04/29 | 04/29 | | |
